Evidence checked as of October 2026. Written by The Wellness Team.
What does a DEXA visceral fat result measure?
A DEXA scan uses low-dose X-ray absorptiometry to map body composition region by region: bone, lean tissue and fat. From the fat distribution around the abdomen, the software estimates visceral adipose tissue, the fat stored deep inside the abdominal cavity around the organs. The result is usually shown as a mass, a volume or a score against reference ranges.
The useful question is not whether the number is flattering. It is whether it changes a decision about training, food, further investigation or follow-up. That starts with understanding what the scan does and does not show.
Why does visceral fat matter more than weight or BMI?
Fat stored around the organs behaves differently from fat stored under the skin. A 2019 international position statement in The Lancet Diabetes and Endocrinology describes visceral and ectopic fat as metabolically active depots linked to insulin resistance, abnormal lipids, fatty liver and cardiovascular disease. Two people with the same BMI can carry very different amounts of visceral fat, which is one reason BMI alone is a blunt screening tool.
This is the gap a DEXA result fills. It locates the fat rather than simply weighing it, and it gives a baseline you can measure change against.
Is a raised visceral fat result the same as a diagnosis?
No. It is a body composition finding, not a diagnosis of diabetes, liver disease or heart disease. It is a reason to look at the rest of the picture: blood pressure, lipids, HbA1c, liver enzymes, fitness, alcohol, sleep and family history. Many people with a raised reading have normal blood markers. The finding still matters, because visceral fat tends to track risk before those markers move.
Can the scan be misleading?
Partly. The visceral fat figure is an estimate derived from the abdominal region, not a direct measurement of every fat depot. Results can vary with the scanner, the software version, hydration and positioning. Small changes between scans should not be over-read. The useful signal is the trend across scans done the same way, on the same machine, over months.
This does not make the scan useless. It means the number belongs in a clinical conversation, not in isolation on a dashboard.
What can the result change?
A measured baseline makes the plan concrete. Visceral fat responds to the ordinary fundamentals done consistently: regular aerobic and resistance training, food quality, alcohol kept within sensible limits, adequate sleep and, where appropriate, medical weight management discussed with a clinician. A repeat scan after a defined period, typically six to twelve months, shows whether the plan is working in the tissue that matters.
A single scan cannot tell you which diet will suit you or promise that disease will be prevented. Evidence for the measure and evidence for a branded screening package are different questions.
When should symptoms take priority over screening?
Body composition scanning is not a route for investigating symptoms. New abdominal pain, persistent bloating, unexplained weight loss, yellowing of the skin or eyes, or a change in bowel habit should be assessed clinically rather than saved for a future longevity appointment. If you feel acutely unwell, use urgent or emergency care as appropriate.
Choosing a doctor-led longevity assessment in London
The value of a premium assessment is the clinical discussion, an honest account of limitations and a follow-up plan you can act on. Test count alone is not a measure of quality. Ask what each investigation could change and what happens if it finds something unexpected.
As of October 2026, The Online GP executive body-scan option starts from £6,995, including DEXA body composition with visceral fat reporting, a measured VO2 max test, full body MRI and a physician-led review and roadmap. The appropriate scope depends on a clinical discussion; additional investigations and specialist follow-up are confirmed and quoted separately.
Discuss your goals with The Online GP, or read the executive body-scan guide before deciding which assessment fits. Confirm the current inclusions, preparation and follow-up arrangements before booking.
Evidence and limits
Neeland et al., The Lancet Diabetes and Endocrinology 2019: visceral and ectopic fat, atherosclerosis and cardiometabolic disease (international position statement): https://pubmed.ncbi.nlm.nih.gov/31301983/
This is general information, not a diagnosis or a personal treatment plan. Evidence for a body composition measure does not establish that a branded screening bundle improves long-term outcomes. Contact The Online GP to discuss the appropriate route for your circumstances.